| Literature DB >> 35734701 |
Jun Han1,2,3, Yunxiang Hu1,3, Sanmao Liu1,3, Zhenxin Hu2,3, Wenzhong Liu4, Hong Wang1.
Abstract
Background: Many studies have investigated a comparison of the potency and safety of PCV versus VCV modes in spinal surgery in prone position. However, controversy about the maximal benefits of which ventilation modes remains. The main purpose of this meta-analysis was to investigate which one is the optimal ventilation for surgery patients undergoing spine surgery in prone position between the two ventilation modes as PCV and VCV.Entities:
Keywords: ASA, American Society of Anesthesiologists; BMI, body mass index; CVP, central venous pressure; Cdyn, dynamic compliance; HCT, hematocrit; HR, heart rates; Hb, hemoglobin; IOB, intra-operation blood loss; MAP, mean arterial pressure; MD, mean difference; Meta-analysis; NP, not provided; PCV, pressure controlled ventilation; PEEP, Positive End Expiratory Pressure; PILF, Posterior Lumbar Interbody Fusion; POB, post-operation blood loss; Pressure-controlled ventilation; Prone position; RCT, randomized controlled trial; Randomized controlled trials; Spine surgery; VCV, volume controlled ventilation; VT, tidal volume; Volume-controlled ventilation
Year: 2022 PMID: 35734701 PMCID: PMC9207057 DOI: 10.1016/j.amsu.2022.103878
Source DB: PubMed Journal: Ann Med Surg (Lond) ISSN: 2049-0801
Fig. 1Flow diagram of the study selection process for the meta-analysis.
Characteristics of all the trials included in the meta-analysis.
| Study | Country | Study type | Surgical methods | Disease diagnosis | ASA (range) | Anesthesia methods | Mechanical ventilation | VT (ml/kg) | FiO2(%) | PEEP (cmH2O) | Age (years) | Gender M: F | BMI (kg/m2) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Şenay 2016 | Turkey | RCT | spinal surgery | NP | General anesthesia | PCV VCV | 6-8 | NP | 20 | 64.0 ± 7.3 | 18/3 | P | |
| Amir 2020 | Egypt | RCT | PILF | NP | General anesthesia | PCV VCV | 8-10 | 100% | 5 | 44.4 ± 7 | 21/25 | 27.8 ± 1.7 | |
| Jo 2012 | Korea | RCT | lumbar surgery | NP | General anesthesia | PCV VCV | 10 | 50% | 0 | NP | NP | NP | |
| Kang 2016 | Korea | RCT | PILF | NP | NP | General anesthesia | PCV VCV | 8 | 25% | 0 | 64 ± 13 | 9/19 | 24.8 ± 3.3 |
| Bi 2014 | China | RCT | spinal surgery | NP | General anesthesia | PCV VCV | 10 | 50% | 0 | 49 ± 15 | 10/10 | 25 ± 4 | |
| Zhou 2013 | China | RCT | lumbar surgery | lumbar disc herniation, lumbar spondylolisthesis, lumbar fracture | General anesthesia | PCV VCV | 8 | 100% | NP | 53 ± 8 | 17/13 | NP | |
| Peng 2017 | China | RCT | PILF | NP | General anesthesia | PCV VCV | 8 | 70%–80% | NP | 55.35 ± 9.57 | NP | NP | |
| Li 2017 | China | RCT | lumbar surgery | lumbar tuberculosis, lumbar tumor | General anesthesia | PCV VCV | 8 | 25% | 0 | 45.8 ± 11.9 | 25/19 | 26.1 ± 4.2 |
PILF, Posterior Lumbar Interbody Fusion; RCT, randomized controlled trial; NP, not provided; PCV, pressure controlled ventilation; VCV, volume controlled ventilation; ASA, American Society of Anesthesiologists; VT, tidal volume; PEEP, Positive End Expiratory Pressure; BMI, body mass index; , PCV; , VCV.
Fig. 2Risk of bias summary.
Results of the meta-analysis of outcome measures.
| Outcome | Number of studies | Patients PCV/VCV | MD (95% CI) | p Value | Heterogeneity |
|---|---|---|---|---|---|
| Blood loss | 4 | 136/137 | −164.07 [-257.60,-70.53] | 0.0006 | 73 |
| IOB (ml) | 2 | 72/72 | 1.48 [-17.65, 20.62] | 0.88 | 0 |
| POB (ml) | 3 | 118/118 | 0.25 [-0.02, 0.52] | 0.07 | 0 |
| Hb (g/dl) | 3 | 118/118 | 0.62 [-0.29, 1.53] | 0.18 | 0 |
| HCT (%) | 8 | 329/329 | −2.79 [-3.50, −2.07] | <0.00001 | 86 |
| Ppeak (cmH2O) | 4 | 208/209 | 0.06 [-0.91, 1.02] | 0.91 | 93 |
| CVP (mmHg) | 6 | 237/238 | −0.60 [-1.56, 0.37] | 0.23 | 27 |
| HR (beat/min) | 6 | 237/238 | 1.91 [-1.25, 5.06] | 0.24 | 86 |
| MAP (mmHg) | 4 | 68/68 | 6.32 [5.34, 7.31] | <0.00001 | 0 |
| Cdyn (ml/cmH2O) | 6 | 160/161 | 16.64 [7.98, 25.29] | 0.0002 | 35 |
| PaO2/FiO2mmHg |
PCV, pressure controlled ventilation; VCV, volume controlled ventilation; MD, mean difference; IOB, intra-operation blood loss; POB, post-operation blood loss; Hb, hemoglobin; HCT, hematocrit; CVP, central venous pressure; HR, heart rates; MAP, mean arterial pressure; Cdyn, dynamic compliance.
Fig. 3Forest plots and meta-analyses. a: intra-operation blood loss; b: sensitivity analysis of intra-operation blood loss. [95% CI: 95% confidence intervals, df: degrees of freedom, Random: random effects model, Fixed: fixed effects model, IV: inverse variance,]; c. Forest plots of the post-operation blood loss. [95% CI: 95% confidence intervals, df: degrees of freedom, Fixed: fixed effects model, IV: inverse variance,].
Fig. 4aForest plots of the Hemoglobin. [95% CI: 95% confidence intervals, df: degrees of freedom, Fixed: fixed effects model, IV: inverse variance,]; 4b. Forest plots of the Hematocrit. [95% CI: 95% confidence intervals, df: degrees of freedom, Fixed: fixed effects model, IV: inverse variance,].
Fig. 5aForest plots of the Ppeak. [95% CI: 95% confidence intervals, df: degrees of freedom, Random: random effects model, IV: inverse variance,]; 5b, c. Forest plots and meta-analyses. b: CVP; c: sensitivity analysis of CVP. [95% CI: 95% confidence intervals, df: degrees of freedom, Random: random effects model, Fixed: fixed effects model, IV: inverse variance,].
Fig. 6aForest plots of the heart rates. [95% CI: 95% confidence intervals, df: degrees of freedom, Fixed: fixed effects model, IV: inverse variance,]; 6b. Forest plots of the mean arterial pressure. [95% CI: 95% confidence intervals, df: degrees of freedom, Random: random effects model, IV: inverse variance,].
Fig. 7aForest plots of the dynamic compliance. [95% CI: 95% confidence intervals, df: degrees of freedom, Fixed: fixed effects model, IV: inverse variance,]; 7b. Forest plots of the PaO2/FiO2. [95% CI: 95% confidence intervals, df: degrees of freedom, Fixed: fixed effects model, IV: inverse variance,].